Distinguished in Lynch Syndrome

Jordan P. Ellis-Lerner

Mount Sinai Hospital, 
CA 
Distinguished in Lynch Syndrome
Mount Sinai Hospital, 
CA 
OverviewLocationsClinical Research

Overview

Jordan Ellis-Lerner practices in Canada. Mr. Ellis-Lerner is rated as a Distinguished expert by MediFind in the treatment of Lynch Syndrome. His top areas of expertise are Lynch Syndrome, COVID-19, Severe Acute Respiratory Syndrome (SARS), Ovarian Cancer, and Mastectomy.

His clinical research consists of co-authoring 94 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 8 articles in the study of Lynch Syndrome.

Gender
Male

Locations

Mount Sinai Hospital, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Genetics Adviser: Evaluating a Digital Decision Support Tool for Genetic Results
Genetics Adviser: Evaluating a Digital Decision Support Tool for Genetic Results
Enrollment Status: Completed
Publish Date: May 31, 2024
Intervention Type: Behavioral
Study Phase: Not Applicable
The Health Outcomes, Utility, and Costs of Returning Incidental Genomic Findings
The Health Outcomes, Utility, and Costs of Returning Incidental Genomic Findings
Enrollment Status: Active_not_recruiting
Publish Date: December 06, 2023
Intervention Type: Other
Study Phase: Not Applicable
Randomized Controlled Trial of a Decision Aid for Incidental Genomic Findings
Randomized Controlled Trial of a Decision Aid for Incidental Genomic Findings
Enrollment Status: Completed
Publish Date: April 17, 2018
Intervention Type: Other
Study Phase: Not Applicable
View 2 Less Clinical Trials

93 Total Publications

Trends in the Utilization of BRCA1 and BRCA2 Testing After the Introduction of a Publicly Funded Genetic Testing Program.
Trends in the Utilization of BRCA1 and BRCA2 Testing After the Introduction of a Publicly Funded Genetic Testing Program.
Journal: Current oncology (Toronto, Ont.)
Published: June 20, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Ellis-Lerner's expertise for a condition
ConditionClose
    View All 13 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile